In vitro activity of the new glycopeptide LY333328 against multiply resistant gram-positive clinical isolates

被引：28

作者：

Garcia-Garrote, F ^{[1
]}

Cercenado, E ^{[1
]}

Alcala, L ^{[1
]}

Bouza, E ^{[1
]}

机构：

[1] Hosp Gen Univ Gregorio Maranon, Microbiol Serv, Madrid 28007, Spain

来源：

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 1998年 / 42卷 / 09期

关键词：

D O I：

10.1128/AAC.42.9.2452

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

The in vitro activity of LY333328 was compared with those of vancomycin and teicoplanin against 425 grampositive clinical isolates? including a variety of multiply resistant strains. LY333328 at less than or equal to 4 mu g/ml inhibited all microorganisms tested, including methicillin- and teicoplanin-resistant staphylococci, glycopeptide-resistant enterococci, penicillin- and multiply resistant pneumococci, and viridans and beta-hemolytic streptococci.

引用

页码：2452 / 2455

页数：4

共 12 条

[1] SECULAR TRENDS IN NOSOCOMIAL PRIMARY BLOOD-STREAM INFECTIONS IN THE UNITED-STATES, 1980-1989 [J].

BANERJEE, SN ;

EMORI, TG ;

CULVER, DH ;

GAYNES, RP ;

JARVIS, WR ;

HORAN, T ;

EDWARDS, JR ;

TOLSON, J ;

HENDERSON, T ;

MARTONE, WJ .

AMERICAN JOURNAL OF MEDICINE, 1991, 91 :S86-S89

[2] In vitro antibacterial activity of LY333328, a new semisynthetic glycopeptide [J].

Biavasco, F ;

Vignaroli, C ;

Lupidi, R ;

Manso, E ;

Facinelli, B ;

Varaldo, PE .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (10) :2165-2172

[3] Comparative activities of LY 333328, a new glycopeptide, against penicillin-susceptible and -resistant pneumococci [J].

Fasola, E ;

Spangler, SK ;

Ednie, LM ;

Jacobs, MR ;

Bajaksouzian, S ;

Appelbaum, PC .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (11) :2661-2663

[4] METHICILLIN-RESISTANT STAPHYLOCOCCI - DETECTION METHODS AND TREATMENT OF INFECTIONS [J].

HACKBARTH, CJ ;

CHAMBERS, HF .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (07) :995-999

[5] In vitro activity and spectrum of LY333328, a novel glycopeptide derivative [J].

Jones, RN ;

Barret, MS ;

Erwin, ME .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (02) :488-493

[6] Pharmacodynamic evaluation of a new glycopeptide, LY333328, and in vitro activity against Staphylococcus aureus and Enterococcus faecium [J].

Mercier, RC ;

Houlihan, HH ;

Rybak, MJ .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (06) :1307-1312

[7]

*NAT COMM CLIN LAB, 1995, PERF STAND ANT SUSC

[8] Semisynthetic glycopeptide antibiotics derived from LY264826 active against vancomycin-resistant enterococci [J].

Nicas, TI ;

Mullen, DL ;

Flokowitsch, JE ;

Preston, DA ;

Snyder, NJ ;

Zweifel, MJ ;

Wilkie, SC ;

Rodriguez, MJ ;

Thompson, RC ;

Cooper, RDG .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (09) :2194-2199

[9] In vitro activity of LY333328, an investigational glycopeptide antibiotic, against enterococci and staphylococci [J].

Schwalbe, RS ;

McIntosh, AC ;

Qaiyumi, S ;

Johnson, JA ;

Johnson, RJ ;

Furness, KM ;

Holloway, WJ ;

SteeleMoore, L .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (10) :2416-2419

[10]

WILKIE SC, 1995, 35 INT C ANT AG CHEM, P156

← 1 2 →